Завершено
Фаза I–II
Беларусь
Lenalidomide; Lenalidomide; Obinutuzumab Injection [Gazyva] · Vitebsk Regional Clinical Cancer Centre
Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.